News
Shares of Amgen Inc. AMGN rallied 1.13% to $290.33 Friday, on what proved to be an all-around great trading session for the ...
It sounds too simple to be true. Exercise works just as effectively as a drug to slash the risk of dying from bowel cancer, ...
21h
Investor's Business Daily on MSNThe Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
The Humankind U.S. Stock ETF (HKND) struggles with diversification, average quality, and unproven strategies. Read an ...
Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...
The aquarium will be developed on a one-acre plot at an estimated cost of ₹50 crore. This special project will be carried out ...
The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...
Historically linked to an anti-duelling group, Daniel O’Connell and the East India Company, today properties on ‘the Green’ house the offices of global corportations, an online retail giant and ...
Columbus City Schools receive $740K to launch hands-on manufacturing programs, preparing students for Ohio’s high-demand STEM ...
Air Products and Chemicals Inc. (NYSE:APD) provides atmospheric gases, process and specialty gases, equipment, and related ...
Late-stage results Otsuka presented in IgA nephropathy triggered a sell-off in Vera shares. Elsewhere, investors scrutinized ...
23h
Zacks.com on MSNWhy Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report?Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results